Results 91 to 100 of about 1,710 (222)
Abstract Background Specimens contaminated with intravenous (IV) fluids can lead to considerable measurement errors in complete blood counts (CBCs), posing challenges for laboratory operations and clinical decision‐making. There is no gold‐standard method for retrospectively identifying these events, making it difficult to target quality improvement ...
Carly Maucione +5 more
wiley +1 more source
Background: Administration of anticoagulant citrate and dextrose (ACD-A) chelates ionized calcium in blood and causes hypocalcemia in plateletpheresis donors.
Prashant Kumar Pandey +3 more
doaj +1 more source
Assessing Changes in Platelet and White Blood Cell Counts and the Risk of Bacterial Contamination during Storage of Single Donor Platelets: A Cross-sectional Study [PDF]
Introduction: Single Donor Platelets (SDP) is crucial in managing thrombocytopenia and other platelet-related disorders. Compared with random donor platelets, SDPs minimise donor exposure and reduce the risk of alloimmunisation.
Harshita +2 more
doaj +1 more source
Scalable Production of Equine Platelet Lysate for Multipotent Mesenchymal Stromal Cell Culture [PDF]
Translation of multipotent mesenchymal stromal cell (MSC)-based therapies is advancing in human and veterinary medicine. One critical issue is the in vitro culture of MSC before clinical use.
Aurich, S. +8 more
core +1 more source
Exploring the immunomodulatory impacts of blood manufacturing consolidation
Abstract Introduction The immunomodulatory consequences of blood transfusion, known as transfusion‐related immune modulation (TRIM), are often not captured by hemovigilance systems. Changes to blood product manufacturing processes may impact patient outcomes.
Amanda Kauffman +11 more
wiley +1 more source
Abstract Background Cryoprecipitate Anti‐Haemophilic Factor (CRYO‐AHF) is enriched for fibrinogen, VWF, FVIII, FXIII and fibronectin, but has short post‐thaw expiration due to risk of transfusion‐transmitted infection (TTI) limiting availability for rapid treatment.
Florian Tupin +6 more
wiley +1 more source
Hematological Changes in the Platelet Apheresis Donors - An Observational Study [PDF]
Introduction: The demand for platelet concentrates is increasing for treating patients in clinics such as oncology. Single Donor Platelets (SDPs) collected through apheresis offer a lower risk of transfusion-related complications.
Anjali Sharma, Satish Arakeri, Rahul Kanungo, Sajal Pagi
core +2 more sources
Motivational Differences between Whole Blood and Apheresis Donors in Quebec, Canada: A Questionnaire-Based Survey in a Voluntary Nonremunerated Context [PDF]
Background. Finding ways to recruit apheresis donors is crucial. The aim of this study was to provide a quantitative analysis of the motivations of regular plasma/platelets donors (PPDs) in comparison with those of regular whole blood donors (WBDs), in a
Johanne Charbonneau +2 more
core +4 more sources
The Safe and Effective Plateletpheresis
At the Research and Production Center of Transfusion platelet production have mainly supported (about 99%) by apheresis. However, apheresis donations have limitations caused by donor fitness due to both their preferences and their platelet pre-count validity.
Bibekov Z +4 more
openaire +1 more source
Factors associated with platelet yield in single-donor platelets
Objective: To identify factors associated with platelet yield in single-donor platelets. Material and Methods: Two-hundred donors who underwent plateletpheresis by an intermittent-flow automatic blood cell separator from November 2001- October 2003 in ...
S Maneewan
doaj

